アジア太平洋のターゲットシーケンシング市場：用途別、製品タイプ別、ターゲットエンリッチメント法別、ターゲットキャプチャタイプ別、エンドユーザー別、国別 - 分析と予測（2024年～2033年）

アジア太平洋のターゲットシーケンシングの市場規模は、2023年に5億7,420万米ドルとなりました。

同市場は、2024年から2033年にかけて14.35%のCAGRで拡大し、2033年には21億7,550万米ドルに達すると予測されています。アジア太平洋のターゲットシーケンシング市場は競争が激しく、既存企業と新興企業が市場シェアを争っています。今後数年間は、市場の成長と変革が予想され、チャンスと課題の両方が存在するため、市場のダイナミックかつ急速な変化を注視することが極めて重要になるとみられています。

手頃な価格で高精度のシーケンス技術に対する需要の高まり、精密医療の利用の拡大、ゲノミクスの進歩はすべて、アジア太平洋のターゲットシーケンシング市場の顕著な成長に寄与しています。全ゲノムシーケンスに代わるコスト効率が高く効率的な手法であるため、特定の遺伝子や関心領域に特化したターゲットシーケンシングはますます普及しています。強力な政府資金、研究イニシアチブの拡大、バイオテクノロジー部門の拡大により、中国、日本、韓国、インドなどの国が市場を独占しています。

がんや遺伝性疾患などの慢性疾患の増加により、臨床診断や個別化治療レジメンへのターゲットシーケンシングの利用が増加しています。次世代シーケンシング（NGS）プラットフォームの技術開拓や、学術機関と企業間のパートナーシップの拡大により、市場は拡大しています。さらに、アジア太平洋は人口が多く、ゲノミクスに基づくヘルスケアに対する意識の高まりも相まって、市場関係者にとって大きなビジネスチャンスとなっています。

さらに、ターゲットシーケンシングは、データ解析を簡素化しながら遺伝的変異をより深く理解できる費用対効果の高さから、臨床および研究用途に特に魅力的です。アジア太平洋のターゲットシーケンシング市場は、ゲノム研究への投資が増加し、同地域における精密医療とゲノム研究の進展に寄与することから、大きく成長すると予想されます。

当レポートでは、アジア太平洋のターゲットシーケンシング市場について調査し、市場の概要とともに、用途別、製品タイプ別、ターゲットエンリッチメント法別、ターゲットキャプチャタイプ別、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

• 動向：現在および将来の影響評価
• ターゲットシーケンシングワークフロー
• 研究開発レビュー
• 規制状況
• 市場力学：概要

第2章 地域

• 地域別概要
• 促進要因と抑制要因
• アジア太平洋
  • 地域概要
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他

第3章 市場-競合ベンチマーキングと企業プロファイル

• 今後の見通し
• 競合情勢
  • BGI Group
  • Daicel Corporation
  • Takara Bio Inc.

第4章 調査手法

List of Figures

• Figure 1: Asia-Pacific Targeted Sequencing Market, $Million, 2024, 2027, and 2033
• Figure 2: Targeted Sequencing Market (by Region), $Million, 2023, 2027, and 2033
• Figure 3: Asia-Pacifc Targeted Sequencing Market (by Application), $Million, 2023, 2027, and 2033
• Figure 4: Asia-Pacifc Targeted Sequencing Market (by Target Enrichment Method), $Million, 2023, 2027, and 2033
• Figure 5: Asia-Pacifc Targeted Sequencing Market (by Target Capture), $Million, 2023, 2027, and 2033
• Figure 6: Asia-Pacifc Targeted Sequencing Market (by End User), $Million, 2023, 2027, and 2033
• Figure 7: Asia-Pacifc Targeted Sequencing Market (by Product Type), $Million, 2023, 2027, and 2033
• Figure 8: Key Industrial Developments in Targeted Sequencing Market, 2023
• Figure 9: Workflow of Targeted Sequencing
• Figure 10: Targeted Sequencing Market, Number of Patents (by Country), January 2019-February 2024
• Figure 11: Targeted Sequencing Market (by Year), January 2019-February 2024
• Figure 12: China Targeted Sequencing Market, $Million, 2023-2033
• Figure 13: India Targeted Sequencing Market, $Million, 2023-2033
• Figure 14: Japan Targeted Sequencing Market, $Million, 2023-2033
• Figure 15: South Korea Targeted Sequencing Market, $Million, 2023-2033
• Figure 16: Australia Targeted Sequencing Market, $Million, 2023-2033
• Figure 17: Rest-of-Asia-Pacific Targeted Sequencing Market, $Million, 2023-2033
• Figure 18: Share of Strategic Initiatives
• Figure 19: Data Triangulation
• Figure 20: Top-Down and Bottom-Up Approach
• Figure 21: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Targeted Sequencing Market, Opportunities
• Table 3: Targeted Sequencing Market, Trend Analysis
• Table 4: Some Product Launches in the Targeted Sequencing Market
• Table 5: Targeted Sequencing Market, Key Partnerships and Collaborations
• Table 6: Targeted Sequencing Market, Regulatory Landscape
• Table 7: Impact Analysis of Market Navigating Factors, 2023-2033
• Table 8: Comparison Between Types of Next-Generation Sequencing Techniques
• Table 9: Targeted Sequencing Market (by Region), $Million, 2023-2033
• Table 10: Asia-Pacific Targeted Sequencing Market (by Application), $Million, 2023-2033
• Table 11: Asia-Pacific Targeted Sequencing Market (by End User), $Million, 2023-2033
• Table 12: Asia-Pacific Targeted Sequencing Market (by Product Type), $Million, 2023-2033
• Table 13: Asia-Pacific Targeted Sequencing Market (by Target Enrichment Methods), $Million, 2023-2033
• Table 14: Asia-Pacific Targeted Sequencing Market (by Type of Target Capture), $Million, 2023-2033
• Table 15: China Targeted Sequencing Market (by End User), $Million, 2023-2033
• Table 16: China Targeted Sequencing Market (by Product Type), $Million, 2023-2033
• Table 17: India Targeted Sequencing Market (by End User), $Million, 2023-2033
• Table 18: India Targeted Sequencing Market (by Product Type), $Million, 2023-2033
• Table 19: Japan Targeted Sequencing Market (by End User), $Million, 2023-2033
• Table 20: Japan Targeted Sequencing Market (by Product Type), $Million, 2023-2033
• Table 21: South Korea Targeted Sequencing Market (by End User), $Million, 2023-2033
• Table 22: South Korea Targeted Sequencing Market (by Product Type), $Million, 2023-2033
• Table 23: Australia Targeted Sequencing Market (by End User), $Million, 2023-2033
• Table 24: Australia Targeted Sequencing Market (by Product Type), $Million, 2023-2033
• Table 25: Rest-of-Asia-Pacific Targeted Sequencing Market (by End User), $Million, 2023-2033
• Table 26: Rest-of-Asia-Pacific Targeted Sequencing Market (by Product Type), $Million, 2023-2033"

Introduction to Asia-Pacific Targeted Sequencing Market

The Asia-Pacific targeted sequencing market was valued at $574.2 million in 2023 and is expected to reach $2,175.5 million by 2033, growing at a CAGR of 14.35% between 2024 and 2033. The APAC targeted sequencing market is fiercely competitive, with both established players and emerging companies vying for market share. It will be crucial to keep an eye on the market's dynamic and quickly changing landscape in the upcoming years as a result of its anticipated growth and transformation, which present both opportunities and challenges.

Market Introduction

The growing demand for affordable, high-accuracy sequencing technologies, the growing use of precision medicine, and genomics advancements are all contributing to the notable growth of the APAC targeted sequencing market. Because it provides a cost-effective and efficient substitute for whole genome sequencing, targeted sequencing-which concentrates on particular genes or regions of interest-is becoming more and more popular. Thanks to strong government funding, growing research initiatives, and the expanding biotechnology sector, nations like China, Japan, South Korea, and India are dominating the market.

The use of targeted sequencing for clinical diagnostics and individualized treatment regimens has increased due to the rise in chronic diseases, such as cancer and genetic disorders. The market is growing as a result of technological developments in next-generation sequencing (NGS) platforms and growing partnerships between academic institutions and business entities. Additionally, the APAC region's large population, coupled with growing awareness about genomics-based healthcare, creates significant opportunities for market players.

Furthermore, targeted sequencing is particularly appealing for clinical and research applications due to its cost-effectiveness, which allows for deeper understanding of genetic variations while simplifying data analysis. The APAC targeted sequencing market is expected to grow significantly as genomics research investments rise, contributing to the advancement of precision medicine and genomic research in the region.

Market Segmentation

Segmentation 1: by Application

• Cancer
• Reproductive Health
• Hereditary Diseases
• Neurological Disorders
• Infectious Diseases
• Cardiovascular Diseases
• Rare Diseases
• Other Applications

Segmentation 2: by End User

• Diagnostic and Clinical Laboratories
• Academic and Research Institutions
• Pharmaceutical and Biotech Companies
• Other End Users

Segmentation 3: by Product Type

• Instruments
• Services
• Kits/Panels and Assays
• Others

Segmentation 4: by Target Enrichment Method

• Hybridization Capture
• Amplicon Sequencing
• Other Target Enrichment Methods

Segmentation 5: by Target Capture

• Targeted DNA Sequencing
• Targeted RNA Sequencing
• Other Types of Target Capture

Segmentation 6: by Country

• China
• Japan
• South Korea
• India
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific targeted sequencing market (by application) has been segmented into detailed segments of the application of targeted sequencing based on applications, including cancer, reproductive health, hereditary diseases, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases, and other applications.

Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enable prominent players to command premium prices while maintaining growth in revenue and volume.

Competitive Strategy: Key players in the Asia-Pacific targeted sequencing market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific targeted sequencing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations are expected to aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some of the prominent companies in this market are:

• BGI Group
• Daicel Corporation
• Takara Bio Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Increasing Number of Targeted Sequencing Products and Services in the Market
  • 1.1.2 Increasing Synergistic Partnerships between Market Players
• 1.2 Targeted Sequencing Workflow
• 1.3 Research and Development Review
  • 1.3.1 Patent Filing Trend (by Country, Year)
• 1.4 Regulatory Landscape
• 1.5 Market Dynamics: Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Increasing Demand for High Depth of Coverage in Sequencing
    • 1.5.1.2 Cost and Data Management Benefits of Targeted Sequencing as Compared to WGS
  • 1.5.2 Market Restraints
    • 1.5.2.1 Lack of Advanced Genomic Testing Centers
    • 1.5.2.2 Lack of Knowledge about New Genes
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Increasing Use in Clinical Research and Trials for Better Disease Pathogenesis and/or Clinical Relevance
    • 1.5.3.2 Increasing Adoption in Targeted Therapeutics in Oncology

2 Regions

• 2.1 Regional Summary
• 2.2 Drivers and Restraints
• 2.3 Asia-Pacific
  • 2.3.1 Regional Overview
    • 2.3.1.1 Driving Factors for Market Growth
    • 2.3.1.2 Factors Challenging the Market
  • 2.3.2 Application
  • 2.3.3 Product
  • 2.3.4 China
  • 2.3.5 Application
  • 2.3.6 Product
  • 2.3.7 India
  • 2.3.8 Application
  • 2.3.9 Product
  • 2.3.10 Japan
  • 2.3.11 Application
  • 2.3.12 Product
  • 2.3.13 South Korea
  • 2.3.14 Application
  • 2.3.15 Product
  • 2.3.16 Australia
  • 2.3.17 Application
  • 2.3.18 Product
  • 2.3.19 Rest-of-Asia-Pacific
  • 2.3.20 Application
  • 2.3.21 Product

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Next Frontiers
• 3.2 Competitive Landscape
  • 3.2.1 BGI Group
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers
    • 3.2.1.5 Key Personnel
    • 3.2.1.6 Analyst View
  • 3.2.2 Daicel Corporation
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers
    • 3.2.2.5 Key Personnel
    • 3.2.2.6 Analyst View
  • 3.2.3 Takara Bio Inc.
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers
    • 3.2.3.5 Key Personnel
    • 3.2.3.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast